The Immune System – News and Features

News
Inovio at ASGT 9th Annual Meeting
Inovio’s presentation showcase potential for electroporation in delivering DNA vaccines.

News
ThermoGenesis and Netcord Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims
These patents relate to the collection, cryopreservation and storage of hematopoietic stem cell - containing umbilical cord blood.

News
GSK Licenses Cancer Antigen Portfolio From Ludwig Institute for Cancer Research
GSK has licensed from LICR a significant number of cancer antigens expressed in a large variety of cancers.

News
Life Science Pharmaceuticals Acquires Monoclonal Antibody Programs from LICR
Company plans to exploit the targeting attributes of certain product candidates by attaching tumor-fighting payloads to the antibodies.

News
Moffitt and Inovio Announce Positive Results from Human Study of Plasmid DNA Delivery Using Electroporation
Collaborators encouraged by interim data from phase I clinical study of patients with malignant melanoma.

News
Experimental flu Vaccine Bypasses Needles by Patricia Reaney
PowderMed says it would move into bigger tests of its vaccine, which uses DNA from the flu virus to stimulate immunity.

News
NIH Names Fisher Unit, Pierce, Preferred Vendor for Multiplex Protein Profiling
Pierce will provide standardized, sensitive multiplex analysis for secreted protein expression in samples submitted by the NIH.

News
Inovio Highlights Clinical and Technology Platforms for DNA Vaccines
The technology, based on the process of electroporation, uses extremely short electrical field pulses to temporarily open cell.

News
For Stanford Scientists, RNAi Gene Therapy Takes two Steps Forward, one Step Back
If RNAi is going to be viable as a therapy for organ-wide diseases such as hepatitis B or C, it will have to stick around.

News
Invitrogen Announces Broad Kinase Screening Agreement with Locus Pharmaceuticals
Screening program will utilize Invitrogen's SelectScreen™ platform
Advertisement